How should I manage a 71-year-old male with diabetes mellitus, hypertension, and hyperlipidemia who presents with chest pain, a normal stress test, and sinus rhythm on electrocardiogram?

Management of Chest Pain with Normal Stress Test in High-Risk Patient

In this 71-year-old diabetic patient with chest pain but a normal stress test and sinus rhythm on ECG, you should discharge him on guideline-directed medical therapy (GDMT) including aspirin, statin, ACE inhibitor (or ARB), and beta-blocker, with close outpatient follow-up to consider evaluation for ischemia with no obstructive coronary artery disease (INOCA) if symptoms persist. 1

Risk Stratification and Testing Strategy

This patient falls into the intermediate-risk category with no known CAD based on his age, diabetes, hypertension, and hyperlipidemia. According to the 2021 ACC/AHA chest pain guidelines, a negative stress test within the past year (assuming adequate stress was achieved) is sufficient to rule out obstructive coronary disease in intermediate-risk patients 1.

Key Decision Points:

• Normal stress test = low likelihood of obstructive CAD: The patient can be safely discharged without proceeding to invasive coronary angiography 1
• Long-term prognosis is excellent: Community-based data shows that patients with chest pain, normal resting ECG, and negative stress testing have a 5-year mortality rate of only 1.2% and combined event rate of 3.8% 2

Guideline-Directed Medical Therapy (GDMT)

Despite the negative stress test, this patient requires aggressive cardiovascular risk factor management given his multiple comorbidities:

Antiplatelet Therapy

• Aspirin for secondary prevention in a diabetic patient with cardiovascular risk factors

Lipid Management

• High-intensity statin therapy is essential given diabetes, hypertension, and age >70

Blood Pressure Control

• Target BP <140/90 mmHg (or <130/80 mmHg if tolerated without orthostatic hypotension) 3
• First-line: ACE inhibitor or ARB - particularly beneficial in diabetic patients for both cardiovascular and renal protection 4, 5
• Second-line: Long-acting calcium channel blocker if additional BP control needed 5
• Beta-blocker consideration: While beneficial for angina relief, use cautiously in diabetics due to potential masking of hypoglycemia symptoms 4

Diabetes Management

• Optimize glycemic control with attention to cardiovascular-protective agents (SGLT2 inhibitors or GLP-1 agonists if appropriate)

Critical Pitfalls to Avoid

Orthostatic hypotension screening is mandatory in this elderly diabetic patient before intensifying antihypertensive therapy. Check BP in both sitting and standing positions 3. Excessive BP lowering (particularly diastolic <60 mmHg) should be avoided, especially if coronary artery disease is present 3.

Do not dismiss persistent or worsening symptoms: If chest pain continues or worsens despite GDMT, the patient should be expeditiously re-evaluated 4. Consider:

• INOCA pathway evaluation as an outpatient for frequent or persistent symptoms 1
• Coronary CTA if symptoms progress, as it may detect non-obstructive plaque not identified on stress testing 1
• Vasospastic angina evaluation if symptoms are episodic and occur at rest 4

Follow-Up Strategy

• Close outpatient monitoring to assess:

  • Symptom resolution or progression
  • Adherence to and tolerance of GDMT
  • Achievement of BP, lipid, and glycemic targets
  • Development of orthostatic symptoms

• Repeat testing indications: Only pursue additional cardiac testing if symptoms worsen or new high-risk features develop. Routine follow-up coronary CTA is not recommended in established or suspected CAD 4

The normal stress test provides strong reassurance in this intermediate-risk patient, but the underlying atherosclerotic risk factors demand aggressive medical management to prevent future cardiovascular events.